Abstract
Introduction: Endometrial carcinomas (EC) can be classified by histopathological types or, more recently, by molecular categories such as those based on tumor-related immune response. There is evidence that the modulation of the immune response can favor or oppose tumor development and evolution. Some markers of the immune response and targeted therapies are already available, although no…